secwatch.observer — SEC 8-K summary
======================================

Issuer:     CENTENE CORP (CNC)
CIK:        0001071739
Form:       8-K
Filed at:   2023-02-07T23:59:59+00:00
Accession:  0001071739-23-000024
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Centene Q4 adj EPS $0.86, full-year adj EPS $5.78; revenue $144.5B (+15% YoY); guidance raised
--------------------------------------------------------------------------------

- Q4 total revenues $35.6B (+9% YoY); full-year 2022 revenues $144.5B (+15% YoY).
- Q4 GAAP diluted EPS $(0.38) includes $528M in impairments; adjusted diluted EPS $0.86.
- Full-year 2022 adjusted diluted EPS $5.78 (+12% YoY); health benefits ratio 87.7%.
- Completed five divestitures (Magellan Rx, Magellan Specialty Health, Ribera Salud, Centurion, HealthSmart).
- 2023 premium/service revenue guidance raised $2B to $131.5B-$133.5B; adj EPS guidance unchanged $6.25-$6.40.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/0001071739-23-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1071739/000107173923000024/cnc-20230207.htm
  HTML page:      https://secwatch.observer/filing/0001071739-23-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer